Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Thoracic Cancer
|
November 25, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan
John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Therapeutic Advances in Respiratory Disease
|
October 28, 2022
Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
Ping-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Cancers
|
October 27, 2022
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients
Yan-Jei Tang, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Thoracic Cancer
|
August 1, 2023
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib
Chen-Te Wu, Ping-Chih Hsu, John Wen-Cheng Chang, et al.
Anticancer Research
|
March 29, 2022
Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring <i>EGFR</i> Mutations
Chi-Han Chen, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Targeted Oncology
|
July 27, 2019
Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib
Chih-Hsi Scott Kuo, Chi-Hsien Huang, Chien-Ying Liu, et al.
Thoracic Cancer
|
April 17, 2025
Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib
Zi-Ting Chang, Ping-Chih Hsu, How-Wen Ko, et al.
BMC Cancer
|
March 25, 2021
A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed
Chih-Hsi Scott Kuo, Pi-Hung Tung, Allen Chung-Cheng Huang, et al.
Thoracic Cancer
|
April 6, 2019
Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
Chih-Hsi Scott Kuo, Chin-Chou Wang, Yu-Chen Huang, et al.
Immunity, Inflammation and Disease
|
November 22, 2024
Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma
Ting-Yu Lin, Po-Jui Chang, Chun-Yu Lo, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Thoracic Cancer
|
November 25, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan
John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Therapeutic Advances in Respiratory Disease
|
October 28, 2022
Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations
Ping-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Cancers
|
October 27, 2022
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients
Yan-Jei Tang, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Thoracic Cancer
|
August 1, 2023
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib
Chen-Te Wu, Ping-Chih Hsu, John Wen-Cheng Chang, et al.
Anticancer Research
|
March 29, 2022
Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring <i>EGFR</i> Mutations
Chi-Han Chen, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Targeted Oncology
|
July 27, 2019
Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib
Chih-Hsi Scott Kuo, Chi-Hsien Huang, Chien-Ying Liu, et al.
Thoracic Cancer
|
April 17, 2025
Baseline and changes in inflammatory parameters for patients with EGFR-mutated NSCLC treated with afatinib
Zi-Ting Chang, Ping-Chih Hsu, How-Wen Ko, et al.
BMC Cancer
|
March 25, 2021
A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed
Chih-Hsi Scott Kuo, Pi-Hung Tung, Allen Chung-Cheng Huang, et al.
Thoracic Cancer
|
April 6, 2019
Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
Chih-Hsi Scott Kuo, Chin-Chou Wang, Yu-Chen Huang, et al.
Immunity, Inflammation and Disease
|
November 22, 2024
Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma
Ting-Yu Lin, Po-Jui Chang, Chun-Yu Lo, et al.
Page
of 4